Introduction
============

COPD is a leading cause of morbidity and mortality worldwide, and its prevalence is increasing.[@b1-copd-13-299] It is characterized by progressive irreversible airflow limitation related to chronic airway inflammation.[@b2-copd-13-299] It is currently ranked the fourth most common cause of death in the United States, and is expected to become the third most common cause by 2020.[@b1-copd-13-299] Most patients with COPD experience exacerbation of respiratory symptoms and frequent hospitalization, resulting in enormous economic costs and debilitating conditions. Unfortunately, a clear pathogenesis of COPD has not been identified, and thus, it is important to identify and prevent risk factors associated with deterioration of the clinical course.

Like other systemic diseases, the development and progression of COPD is multifactorial. Smoking has been regarded as the most important risk factor for the development of COPD,[@b3-copd-13-299],[@b4-copd-13-299] but never-smoker COPD is reported at \~25%--45%.[@b3-copd-13-299],[@b5-copd-13-299],[@b6-copd-13-299] Several epidemiologic cross-sectional studies reported that elevated air pollution might be associated with the development and acute exacerbation of COPD, hospitalization, and even mortality in patients with COPD.[@b7-copd-13-299]--[@b12-copd-13-299]

Particulate matter (PM) is a complex mixture of small solid particles and liquid droplets in the air. PM with aerodynamic diameters ≤10 µm (PM~10~) has been reported to be associated with increased hospitalization, emergency department visits, and mortality.[@b12-copd-13-299]--[@b14-copd-13-299] Furthermore, PM with aerodynamic diameters ≤2.5 µm (PM~2.5~) may be more directly involved as these fine particles can penetrate more deeply to approach the small airways and exert greater toxicity than PM~10~.[@b8-copd-13-299],[@b10-copd-13-299],[@b15-copd-13-299]

According to a report recently released by the Health Effects Institute in the United States, Korea's average annual PM~2.5~ concentration was 26 µg/m^3^ in 1990, but increased to 29 µg/m^3^ after 2015.[@b16-copd-13-299] Over the same 25 years from 1990 to 2015, the average PM~2.5~ concentration in member countries of the Organisation for Economic Co-operation and Development (OECD) has dropped to 15 µg/m^3^, whereas in Korea, it has risen to the worst level among OECD members excluding Turkey. In Korea, PM~2.5~-related research has been increasing since the recent release of information on PM~2.5~. However, most studies have been conducted in urban areas because air pollution mainly resulting from traffic and industrial processes are relatively more troublesome in urban than in rural areas.

In this study, we aimed to evaluate the association between PM~2.5~ concentration and COPD-related hospital visits and to identify the influence of PM~2.5~ components.

Methods
=======

COPD-related hospital admission data
------------------------------------

COPD-related health care use including hospital visits and admissions from Korean National Health Insurance Service (KNHIS) data have been reported.[@b17-copd-13-299]

Data on COPD-related health care use in Chuncheon, Gangwon-do, between January 1, 2006 and December 31, 2012, were used. The KNHIS has managed a computerized database for all medical facilities since its implementation in 1998 and provides a unique and helpful approach for evaluating the nationwide magnitude of various diseases and related health care use. Medical institutions must report standard computerized claim documents for medical expenses and diagnostic codes for each admission based on the International Classification of Disease 10th (ICD-10) revision. We obtained information on the daily number of hospital visits for COPD according to the ICD-10 codes J44.x. All the KNHIS data used in this study were anonymous and did not contain any personally identifiable information, therefore no patient consent was needed.

Air pollution and meteorological information
--------------------------------------------

Daily levels of PM~2.5~ were measured on the roof of the four-story Kangwon National University Natural Sciences building in Chuncheon once every 3 days from 2006 to 2012. To measure PM~2.5~ mass and metallic components, a 37 mm Teflon filter was used. Carbonaceous compounds were collected on a quartz filter at a flow rate of 16.7 L/min. Ionic components of PM~2.5~ were collected using a three-stage Teflon filter pack after ionic gases (SO~2~, HNO~3~, HNO~2~, and NH~3~) were removed by denuders to prevent both positive and negative artifacts. All ionic components were first collected on a Zefluor filter, and HNO~3~ and NH~3~ volatilized from the Zefluor filter were collected on a nylon filter and paper filter soaked in 1% citric acid, respectively.

For PM~2.5~ mass monitoring, the Teflon filter was stored in temperature- and humidity-controlled conditions for at least 24 hours before and after sampling and then passed through a static electric eliminator (2U500) before being weighed at least twice using an analytical balance. Metallic elements and ionic compounds were analyzed using energy-dispersive X-ray fluorescence (Spectro X-Lab Pro, Kleve, Germany) and ion chromatography (Waters Corporation, Milford, MA, USA), respectively. Carbonaceous compounds including elemental carbon (EC) and organic carbon were analyzed using National Institute for Occupational Safety and Health method 5040.[@b18-copd-13-299] Detailed sampling and analysis methods can be found in previous studies.[@b19-copd-13-299]--[@b22-copd-13-299]

Meteorological data including temperature, humidity, and precipitation were obtained from the Korean Meteorological Administration. Meteorological data and hospital visits were matched to the dates of PM~2.5~ measurement.

Statistical analysis
--------------------

Descriptive data are presented as the mean ± standard deviation, minimum, lower quartile, median, upper quartile, and maximum. The response variable was the frequency of COPD-related hospital visits. Hospital visits occurred sporadically and followed an irregular distribution consisting of various numbers starting with zero. The majority of subjects did not visit a hospital, which may lead to underestimation of the impact of air pollutants on COPD-related hospital visits. Therefore, we applied a zero-inflated Poisson model, which is suitable for rare events with variable lengths of time followed.

The PM~2.5~ constituents-specific risk of hospital visits was analyzed by a Poisson model and expressed as relative risk (RR) with 95% confidence interval (CI). The relationship of PM~2.5~ and its constituents with COPD-related hospital visits was adjusted for covariates including temperature, humidity, precipitation, season, day of the week, and holiday status. Environmental effects may be delayed over a period of several days, and thus, we considered the lagged effects of the day of the event and up to 5 days (from Lag0 to Lag5). All analyses were two-sided and performed at a significance level of 0.05 unless otherwise noted. *P*\<0.05 was considered statistically significant. All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA).

This study was approved by the Institutional Review Board of Kangwon National University Hospital (IRB No 2013-12-011).

Results
=======

Meteorological information
--------------------------

For the period of 6 years from 2006 to 2012, the mean PM~2.5~ concentration was 35.0±25.16 µg/m^3^ (range 1.46--146.99 µg/m^3^) and mean temperature and humidity were 11.36°C±9.47°C (range −8.99°C to 28.33°C) and 70.92%±12.81% (range 38.38%--94.54%), respectively.

There are four distinct seasons in Korea: spring (March through May), summer (June through August), fall (September through November), and winter (December through February). The PM~2.5~ level showed an obvious seasonal variation, with a lower level in summer (19.42±1.39 µg/m^3^) and higher level in winter (42.71±2.08 µg/m^3^). Within a 12-month period, the PM~2.5~ concentration was the highest in December (48.23±3.28 µg/m^3^) and lowest in August (13.43±1.48 µg/m^3^).

Risk of hospital visit for COPD according to PM~2.5~ concentration
------------------------------------------------------------------

The mean numbers of hospital visits for COPD-related respiratory difficulty are presented in [Table 1](#t1-copd-13-299){ref-type="table"}. Hospital visits including both admissions and outpatient clinic visits were more prevalent for males than for females. Mean hospital admission and outpatient clinic visit rates expressed by number per day for COPD were 0.21±0.43 and 8.25±5.36 for males and 0.04±0.19 and 6.21±4.23 for females, respectively.

The risk of a COPD-related hospital visit including admissions and outpatient clinic visits according to PM~2.5~ concentration is presented in [Table 2](#t2-copd-13-299){ref-type="table"}. For every 10 µg/m^3^ increase in PM~2.5~ concentration, total hospital visits increased by 0.26% on Lag2 and Lag3 and by 0.25% on Lag4. When divided by sex, total hospital visits by males significantly increased by 0.32% and 0.25% on Lag3 and Lag4 but increased by 0.40% and 0.58% on Lag1 and Lag2. Hospital admissions were not affected by an increase in PM~2.5~ concentration, but the risk of an outpatient visit increased as the PM~2.5~ concentration increased, similar to total hospital visits.

Risk of hospital visit for COPD according to PM~2.5~ constituents
-----------------------------------------------------------------

The relationship between PM~2.5~ constituents and the risk of COPD-related hospital visits is shown in [Table 3](#t3-copd-13-299){ref-type="table"}. Among the constituents, Al and Si increased COPD-related hospital visits on Lag1 (RR, 1.0; 95% CI, 1.00--1.00, for both) and EC did so on Lag2 (RR, 1.14; 95% CI, 1.02--1.28). The influence of constituents on hospital visits analyzed according to sex is shown in [Table 4](#t4-copd-13-299){ref-type="table"}. In males, Mg, Al, Si, Ti, As, Br, and EC were related to high risk for hospital visits in COPD patients, and especially, As was found to have a greater effect than other constituents (RR, 2.39; 95% CI, 1.00--5.69). However, no significantly associated constituents were found for females.

Discussion
==========

We observed that COPD-related hospital visits including outpatient clinic visits and admissions increased as the PM~2.5~ concentration increased and that some constituents of PM~2.5~ were related to an increased risk of hospital visits in Chuncheon, Korea. Our results demonstrated sex-specific effects on association between exposure to air pollutants and the risk of a hospital visit; females visited the hospital sooner than males and the risk of a hospital visit increased considerably more in females than in males. In our study, 79.9% of males and 96.5% of females did not visit a hospital for aggravation of COPD. This is consistent with the expectation that admission due to deterioration of COPD is a rare event, which might result in underestimation of the impact of PM~2.5~ and its constituents on the risk of exacerbation.

PM, a major component of air pollution, consists of solid and liquid particles that float around in air.[@b23-copd-13-299] Although PM~10~ is usually trapped in the upper airway, PM~2.5~ could approach the terminal bronchiole and alveolar space, and water-soluble pollutants might penetrate alveolar capillaries and then enter the systemic circulation.[@b24-copd-13-299] In this process, inflammatory signals become active and several inflammatory cytokines are released and even pollutants themselves might cause oxidative stress,[@b25-copd-13-299],[@b26-copd-13-299] which contributes to the development and exacerbation of chronic respiratory diseases.[@b27-copd-13-299]

The influence of PM levels on respiratory disease has been reported in several studies, and focused on PM~2.5~; there are epidemiologic data regarding the harmful impact of PM~2.5~ on the higher prevalence,[@b28-copd-13-299] increase of exacerbation and emergency room visits,[@b29-copd-13-299] and mortality of COPD.[@b30-copd-13-299] As the interest in fine dust increases, PM-related studies are on the rise, especially in East Asia, and in China in particular.[@b8-copd-13-299],[@b28-copd-13-299] In Korea, information about PM~2.5~ was released in 2014, and thus, there have been several recent studies related to this. Most of the previous studies were performed in big urban city areas where the sources of PM, including traffic, industry, biomass, and long-range transport, are abundant.[@b14-copd-13-299],[@b31-copd-13-299] However, Chuncheon is a relatively small city comprising \<1% of the population in Korea with 0.28 million inhabitants living mostly in rural areas outside the central district. Because there are no industrial complexes and there is not much traffic, the amount of pollution generated in the area itself is expected to be low, but because Chuncheon is located northeast from Seoul, the capital of Korea, drifting of dust from metropolitan areas over to Chuncheon with westerly winds may be possible. Furthermore, because the city is surrounded by mountains, dust cannot efflux to different locations easily. The World Health Organization defined the daily limit of exposure for PM~2.5~ and PM~10~ as 25 and 50 µg/m^3^, respectively[@b32-copd-13-299]. Considering that the expected amount of dust created in Chuncheon is low, meteorological and geographical factors might explain the high concentration of dust in Chuncheon. Furthermore, a recent study from a rural area of England showed that in a pattern similar to an urban city area, increases in CO and nitrogen oxides concentrations are related to a higher risk of hospital admission for exacerbation of COPD.[@b33-copd-13-299]

After adjustment for meteorological factors that could influence variation of respiratory symptoms, including humidity, temperature, precipitation, and season, we found that PM~2.5~ and some constituents are meaningfully associated with an increment in hospital visits in patients with COPD. However, because the number of hospital admissions during the study period was too low, we found no significant effect of PM~2.5~ on the risk of hospital admission.

Li et al[@b34-copd-13-299] reported an association between PM and its constituents and health-related outcomes and showed K^+^, Ca^2+^, NO^3−^, and SO~4~^2−^ were associated with increased mortality in a 5 year study in Beijing. Son et al[@b35-copd-13-299] estimated the effects of PM~2.5~ and its chemical components on mortality in Seoul and found that Mg, NO~3~, SO~4~, and chlorine exhibited significant associations with mortality. In the present study, some constituents including Al, Si, and EC were related to an increased risk of COPD-related hospital visits; especially, the influence of EC was marked at Lag2. The results of this study are meaningful both clinically and ecologically since the effect of each constituent of PM~2.5~ on COPD-related prognosis was significant. Although COPD is influenced by multiple environmental factors,[@b36-copd-13-299] control of PM~2.5~ emission will benefit patients from increased hospital visits. For effective regulation, understanding of toxic components and sources of PM~2.5~ is needed. In addition, studies on the mechanism of air pollution in the development and exacerbation of COPD will be helpful for prevention strategies.

Some studies have shown sex-specific effects of air pollution on health-related outcomes. Kan et al[@b37-copd-13-299] found that females are more vulnerable to air pollution (PM~10~; SO~2~, NO~2~, and O~3~) than males, and Zanobetti and Schwartz[@b38-copd-13-299] observed that air pollution-related mortality was higher in females than in males. Clear reasons for the adverse effects of air pollution on females are not well known. Sex-specific differences with respect to the effects of air pollution may be related to smaller airways, greater airway reactivity, lung structural differences, and greater deposition of particles in the lungs of females.[@b39-copd-13-299]--[@b41-copd-13-299] A difference in gene expression due to chronic air pollution exposure between males and females has also been reported.[@b42-copd-13-299]

Our study has several limitations to consider. First, the number of hospital visits was obtained from the KNHIS database based on the claimed diagnosis of COPD defined by ICD-10 codes, which may not reflect the patient's actual problem during that hospital visit. Second, the PM~2.5~ concentration was measured in only one place, which thus did not take into account any effect of the distance between the PM~2.5~ measurement site and the residence or principal locus of daily activity. Therefore, the impact of PM~2.5~ might be overestimated or underestimated depending on the distance from the measurement site. Third, there was a lack of demographic information that could influence hospital visits of COPD patients, such as age, smoking history, lung function, perceived quality of life, dyspnea scale, and previous exacerbation history. Fourth, we could not account for indoor air pollutants. Lastly, the low number of hospitalized events in COPD patients could have resulted in an underestimation of the effects of PM~2.5~ and its constituents as well.

Conclusion
==========

In summary, we found a significant association between PM~2.5~ and the risk of COPD-related hospital visits. Furthermore, various constituents of PM~2.5~ might have a positive influence to increase the risk of hospital visits in COPD patients. In addition, there was a difference according to sex in the time until the COPD-related health care event occurred.

This study was supported by a grant from the Ministry of Environment, Republic of Korea.

**Disclosure**

The authors report no conflicts of interest in this work.

###### 

Descriptive statistics of hospital visits in Chuncheon, Korea, from 2006 to 2012

  N/day                  Mean ± SD   Min    Percentiles   Max                           
  ---------------------- ----------- ------ ------------- ------ ------ ------- ------- -------
  **Total**              8.49±5.42   1.00   1.00          5.00   8.00   11.00   18.00   36.00
  Male                   6.42±4.28   0.00   1.00          3.00   6.00   9.00    15.00   23.00
  Female                 2.07±1.93   0.00   0.00          1.00   2.00   3.00    5.00    14.00
  **Admission**          0.24±0.48   0.00   0.00          0.00   0.00   0.00    1.00    2.00
  Male                   0.21±0.43   0.00   0.00          0.00   0.00   0.00    1.00    2.00
  Female                 0.04±0.19   0.00   0.00          0.00   0.00   0.00    0.00    1.00
  **Outpatient visit**   8.25±5.36   0.00   1.00          4.00   8.00   11.00   18.00   35.00
  Male                   6.21±4.23   0.00   1.00          3.00   6.00   8.00    14.00   23.00
  Female                 2.04±1.91   0.00   0.00          1.00   2.00   3.00    5.00    14.00

###### 

Percentage increase in hospital visits and 95% CI as PM~2.5~ increases 10 µg/m^3^

                         Lag1                                               Lag2          Lag3                                               Lag4          Lag5                                                                                                                                      
  ---------------------- -------------------------------------------------- ------------- -------------------------------------------------- ------------- -------------------------------------------------- ------------- -------------------------------------------------- ------------- ------- -------------
  **Total**              0.11                                               −0.07, 0.30   0.26[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.06, 0.46    0.26[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.04, 0.44    0.25[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.05, 0.44    0.10    −0.08, 0.28
  Male                   0.02                                               −0.20, 0.23   0.15                                               −0.07, 0.38   0.32[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.10, 0.53    0.25[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.02, 0.48    0.07    −0.14, 0.28
  Female                 0.40[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.01, 0.78    0.58[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.17, 0.99    0.09                                               −0.27, 0.44   0.25                                               −0.14, 0.63   0.17    −0.19, 0.53
  **Admission**          0.17                                               −0.89, 1.23   0.51                                               −0.72, 1.72   0.99                                               −0.33, 2.29   0.36                                               −0.86, 1.57   −0.68   −1.78, 0.41
  Male                   0.19                                               −0.90, 1.29   0.77                                               −0.70, 2.22   0.83                                               −0.59, 2.24   0.93                                               −0.72, 2.56   0.99    −0.19, 2.19
  Female                 0.40                                               −0.01, 0.81   0.11                                               −0.21, 0.42   0.02                                               −0.45, 0.50   0.05                                               −0.22, 0.32   0.08    −0.23, 0.40
  **Outpatient visit**   0.11                                               −0.07, 0.30   0.25                                               −0.05, 0.45   0.24[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.06, 0.43    0.25[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.05, 0.45    0.12    −1.66, 1.88
  Male                   0.28                                               −1.89, 2.41   0.13                                               −0.09, 0.36   0.30[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.08, 0.52    0.24                                               −0.01, 0.47   0.10    −0.11, 0.32
  Female                 0.36                                               −0.03, 0.74   0.62[\*](#tfn1-copd-13-299){ref-type="table-fn"}   0.20, 1.03    0.44                                               −0.38, 1.10   0.28                                               −0.12, 0.67   0.17    −0.20, 0.53

**Notes:**

*P*≤0.05, which represents statistically significant changes as time progressed. Environmental effects may be delayed over a period of several days, and thus, we considered the lagged effects of the day of the event and up to 5 days (from Lag0 to Lag5).

**Abbreviations:** CI, confidence interval; PM~2.5~, particulate matter with aerodynamic diameters ≤2.5 µm.

###### 

Percentage increase in COPD-related hospital visits and 95% CI in all participants as each particle constituent increased 10 µg/m^3^

       Lag1                                                Lag2             Lag3                                                Lag4            Lag5                                                         
  ---- --------------------------------------------------- ---------------- --------------------------------------------------- --------------- -------- ---------------- -------- ---------------- -------- ----------------
  Na   −0.024                                              −0.086, 0.037    −0.022                                              −0.128, 0.085   −0.005   −0.077, 0.068    −0.029   −0.085, 0.027    0.072    −0.091, 0.234
  Mg   0.044                                               −0.006, 0.094    0.100                                               −0.372, 0.572   0.366    −0.455, 1.188    −0.300   −0.610, 0.010    0.679    −1.371, 2.730
  Al   0.016[\*](#tfn3-copd-13-299){ref-type="table-fn"}   0.000, 0.031     0.065                                               −0.055, 0.185   0.028    −0.066, 0.121    −0.108   −0.220, 0.005    −0.066   −0.253, 0.120
  Si   0.007[\*](#tfn3-copd-13-299){ref-type="table-fn"}   0.000, 0.014     0.031                                               −0.020, 0.082   0.014    −0.024, 0.052    −0.053   −0.107, 0.000    −0.033   −0.119, 0.053
  Cl   −0.034                                              −0.162, 0.094    0.009                                               −0.138, 0.156   −0.058   −0.231, 0.113    −0.059   −0.199, 0.080    −0.056   −0.280, 0.167
  K    0.017                                               −0.027, 0.061    0.038                                               −0.040, 0.115   0.027    −0.046, 0.100    −0.080   −0.153, 0.007    −0.054   −0.202, 0.095
  Ca   0.021                                               −0.001, 0.043    0.073                                               −0.126, 0.272   0.041    −0.154, 0.236    −0.164   −0.339, 0.010    −0.134   −0.461, 0.193
  Ti   0.242                                               −0.008, 0.493    0.729                                               −0.443, 1.900   0.396    −0.529, 1.320    −1.546   −2.964, −0.127   −0.988   −3.370, 1.394
  V    3.370                                               −1.184, 7.925    −1.994                                              −8.585, 4.594   −4.433   −11.317, 2.451   4.309    −3.170, 11.788   −1.129   −10.709, 8.451
  Cr   2.113                                               −1.997, 4.229    2.278                                               −1.846, 4.711   3.212    −3.023, 5.401    0.717    −0.908, 2.342    1.546    −1.366, 4.458
  Mn   0.706                                               −0.150, 1.563    0.571                                               −1.681, 2.823   −0.143   −1.959, 1.674    −0.745   −2.585, 1.095    −0.535   −3.016, 1.946
  Fe   0.023                                               −0.001, 0.048    0.050                                               −0.074, 0.174   0.008    −0.084, 0.101    −0.064   −0.165, 0.036    −0.043   −0.188, 0.101
  Ni   −4.014                                              −7.642, −0.384   −1.827                                              −6.302, 2.647   −1.834   −5.771, 2.102    −0.192   −4.485, 4.101    4.409    −9.373, 18.192
  Cu   −0.332                                              −0.797, 0.131    0.292                                               −0.290, 0.873   0.553    −0.120, 1.227    −1.109   −1.912, 0.307    −0.527   −2.092, 1.039
  Zn   0.016                                               −0.349, 0.383    0.114                                               −0.355, 0.584   −0.026   −0.389, 0.337    −0.137   −0.511, 0.237    −0.130   −0.623, 0.363
  As   −2.260                                              −5.777, 1.256    3.153                                               −2.681, 8.987   1.446    −3.053, 5.946    −5.162   −10.553, 0.227   −3.303   −12.073, 5.468
  Se   −2.700                                              −8.540, 3.139    −1.011                                              −7.361, 5.338   −3.695   −10.738, 3.350   0.500    −6.347, 7.348    −1.123   −10.604, 8.359
  Br   −0.685                                              −2.850, 1.481    1.674                                               −1.137, 4.485   1.414    −1.160, 3.987    −4.834   −8.618, −1.049   −3.932   −11.641, 3.779
  Pb   0.196                                               −0.660, 1.052    0.023                                               −1.162, 1.208   −0.447   −1.918, 1.024    −0.463   −1.598, 0.672    −0.320   −2.248, 1.608
  OC   −0.172                                              −0.474, 0.129    0.118                                               −0.145, 0.382   0.042    −0.244, 0.329    0.044    −0.311, 0.398    −0.118   −0.451, 0.216
  EC   0.751                                               −0.404, 1.906    1.336[\*](#tfn3-copd-13-299){ref-type="table-fn"}   0.218, 2.455    0.417    −0.873, 1.706    −0.862   −2.229, 0.504    0.223    −0.959, 1.406

**Notes:**

*P*≤0.05, which represents statistically significant changes as time progressed. Environmental effects may be delayed over a period of several days, and thus, we considered the lagged effects of the day of the event and up to 5 days (from Lag0 to Lag5).

**Abbreviations:** CI, confidence interval; EC, elemental carbon; OC, organic carbon.

###### 

Percentage increase in COPD-related hospital visits and 95% CI in males and females as each particle constituent increased 10 µg/m^3^

               Lag1                                                Lag2              Lag3                                                Lag4              Lag5                                                          
  ------------ --------------------------------------------------- ----------------- --------------------------------------------------- ----------------- -------- ---------------- -------- ----------------- -------- -----------------
  **Male**                                                                                                                                                                                                               
  Na           −0.031                                              −0.106, 0.045     −0.023                                              −0.152, 0.106     0.003    −0.081, 0.087    −0.042   −0.107, 0.022     0.130    −0.094, 0.355
  Mg           0.059[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.001, 0.116      0.376                                               −0.291, 1.043     0.711    −0.546, 1.968    −0.373   −0.724, −0.023    1.316    −1.291, 3.923
  Al           0.021[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.002, 0.039      0.182[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.002, 0.361      0.010    −0.097, 0.117    −0.126   −0.265, 0.014     −0.122   −0.367, 0.123
  Si           0.009[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.001, 0.018      0.078[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.008, 0.148      0.008    −0.035, 0.052    −0.063   −0.133, 0.005     −0.060   −0.178, 0.057
  Cl           −0.077                                              −0.225, 0.070     0.036                                               −0.137, 0.209     −0.142   −0.343, 0.060    −0.068   −0.231, 0.094     −0.119   −0.397, 0.158
  K            0.021                                               −0.032, 0.075     0.110                                               −0.006, 0.227     0.013    −0.072, 0.098    −0.096   −0.186, −0.008    −0.099   −0.294, 0.097
  Ca           0.028[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.002, 0.053      0.229                                               −0.063, 0.521     −0.018   −0.243, 0.208    −0.192   −0.401, 0.016     −0.234   −0.658, 0.190
  Ti           0.324[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.031, 0.617      1.699[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.197, 3.202      0.310    −0.741, 1.362    −1.981   −3.916, −0.045    −1.886   −5.375, 1.603
  V            3.355                                               −2.110, 8.819     −3.661                                              −11.135, 3.814    −7.785   −15.965, 0.398   5.262    −3.669, 14.193    −3.829   −15.626, 7.968
  Cr           1.708                                               −1.336, 4.049     2.035                                               −1.350, 4.720     2.735    −2.297, 5.174    −0.056   −2.130, 2.010     −0.493   −4.570, 3.584
  Mn           0.855                                               −0.177, 1.886     1.371                                               −1.394, 4.134     −0.825   −2.890, 1.239    −0.754   −2.920, 1.412     −1.192   −4.253, 1.869
  Fe           0.030[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.001, 0.059      0.137                                               −0.037, 0.311     −0.020   −0.126, 0.086    −0.069   −0.189, 0.052     −0.083   −0.267, 0.100
  Ni           −5.920                                              −10.281, −1.561   −3.030                                              −8.205, 2.147     −2.283   −6.722, 2.158    −0.910   −5.944, 4.123     7.795    −18.351, 22.811
  Cu           −0.359                                              −0.919, 0.201     0.601                                               −0.064, 1.265     0.746    −0.030, 1.523    −1.514   −2.584, −0.445    −0.189   −2.165, 1.788
  Zn           −0.079                                              −0.511, 0.352     0.279                                               −0.295, 0.853     −0.164   −0.577, 0.249    −0.139   −0.578, 0.301     −0.270   −0.884, 0.346
  As           −3.351                                              −7.512, 0.809     8.714[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.045, 17.383     0.530    −4.614, 5.673    −6.099   −12.773, 0.576    −6.173   −17.761, 5.418
  Se           −5.232                                              −11.914, 1.448    −1.564                                              −8.819, 5.692     −7.275   −15.630, 1.077   0.490    −7.550, 8.530     −3.745   −15.376, 7.885
  Br           −0.856                                              −3.447, 1.734     3.876[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.340, 7.410      1.302    −1.635, 4.238    −6.840   −12.238, −1.442   −8.630   −22.321, 5.063
  Pb           0.091                                               −0.926, 1.107     0.179                                               −1.208, 1.567     −1.205   −2.942, 0.533    −0.569   −1.890, 0.751     −0.858   −3.227, 1.513
  OC           −0.122                                              −0.458, 0.216     0.120                                               −0.163, 0.404     −0.012   −0.336, 0.310    −0.135   −0.582, 0.312     −0.260   −0.632, 0.111
  EC           0.888                                               −0.454, 2.230     1.489[\*](#tfn5-copd-13-299){ref-type="table-fn"}   0.206, 2.770      0.443    −1.004, 1.890    −1.458   −3.046, 0.130     0.165    −1.078, 1.407
  **Female**                                                                                                                                                                                                             
  Na           −0.009                                              −0.090, 0.073     −0.017                                              −0.179, 0.145     −0.040   −0.133, 0.053    −0.001   −0.073, 0.071     0.055    −0.158, 0.268
  Mg           0.016                                               −0.060, 0.091     −0.189                                              −0.857, 0.479     0.000    −0.964, 0.964    −0.119   −0.517, 0.279     0.467    −2.299, 3.232
  Al           0.006                                               −0.017, 0.030     −0.066                                              −0.244, 0.112     0.087    −0.036, 0.210    −0.085   −0.227, 0.057     −0.051   −0.298, 0.196
  Si           0.003                                               −0.008, 0.013     −0.030                                              −0.112, 0.051     0.034    −0.016, 0.084    −0.042   −0.108, 0.024     −0.026   −0.138, 0.086
  Cl           0.080                                               −0.126, 0.285     −0.052                                              −0.281, 0.176     0.144    −0.103, 0.390    −0.045   −0.230, 0.140     −0.034   −0.339, 0.270
  K            0.014                                               −0.048, 0.076     −0.041                                              −0.153, 0.071     0.072    −0.024, 0.168    −0.054   −0.146, 0.038     −0.041   −0.238, 0.156
  Ca           0.009                                               −0.024, 0.041     −0.103                                              −0.385, 0.179     0.201    −0.057, 0.459    −0.117   −0.342, 0.108     −0.102   −0.539, 0.336
  Ti           0.092                                               −0.282, 0.465     −0.726                                              −2.692, 1.242     0.791    −0.421, 2.002    −1.148   −2.856, 0.559     −0.795   −3.833, 2.243
  V            3.705                                               −3.125, 10.534    0.677                                               −10.871, 12.225   2.487    −7.761, 12.736   2.344    −7.348, 12.037    −0.022   −13.145, 13.100
  Cr           3.209                                               −2.155, 6.263     3.132                                               −1.362, 0.602     4.270    −3.066, 7.474    2.130    −0.500, 4.760     4.074    −0.580, 8.727
  Mn           0.496                                               −0.736, 1.727     −0.812                                              −4.202, 2.577     1.729    −0.744, 4.204    −0.796   −3.206, 1.614     −0.296   −3.664, 3.072
  Fe           0.011                                               −0.024, 0.047     −0.058                                              −0.238, 0.120     0.090    −0.034, 0.213    −0.060   −0.190, 0.070     −0.029   −0.225, 0.167
  Ni           −0.290                                              −5.747, 5.166     0.234                                               −7.304, 7.773     −1.931   −7.358, 3.495    1.026    −4.286, 6.339     4.300    −12.344, 20.944
  Cu           −0.270                                              −0.964, 0.425     −0.303                                              −1.387, 0.783     0.301    −0.681, 1.283    −0.579   −1.537, 0.378     −0.668   −2.780, 1.444
  Zn           0.258                                               −0.303, 0.819     −0.177                                              −0.887, 0.534     0.351    −0.144, 0.845    −0.148   −0.638, 0.341     −0.076   −0.744, 0.591
  As           0.058                                               −5.147, 5.263     −3.097                                              −11.747, 5.552    4.315    −1.576, 10.207   −3.941   −10.738, 2.858    −2.334   −13.955, 9.288
  Se           4.160                                               −5.759, 14.080    −0.632                                              −11.233, 9.971    4.039    −6.413, 14.491   0.276    −8.751, 9.304     −0.063   −13.049, 12.922
  Br           −0.206                                              −3.281, 2.869     −1.723                                              −6.486, 3.040     2.230    −1.160, 5.620    −2.973   −7.354, 1.406     −3.042   −12.438, 6.353
  Pb           0.515                                               −0.760, 1.791     −0.331                                              −2.188, 1.525     1.263    −0.864, 3.390    −0.288   −1.795, 1.219     −0.101   −2.734, 2.532
  OC           −0.356                                              −0.965, 0.254     0.098                                               −0.465, 0.660     0.273    −0.203, 0.749    0.318    −0.176, 0.812     0.256    −0.257, 0.768
  EC           0.340                                               −1.692, 2.372     1.099                                               −1.079, 3.277     0.552    −1.813, 2.919    0.193    −1.892, 2.279     0.366    −1.664, 2.396

**Notes:**

*P*≤0.05, which represents statistically significant changes as time progressed. Environmental effects may be delayed over a period of several days, and thus, we considered the lagged effects of the day of the event and up to 5 days (from Lag0 to Lag5).

**Abbreviations:** CI, confidence interval; EC, elemental carbon; OC, organic carbon.
